Pharma companies with R&D only don't trade like this. Cash is very important. I hate to even post this but if Novel is really big, lets say ~ 10m, I would like them to do a reverse split. Especially if they get the three products launched and get real close to profit on mfg revenues.

I think 10m may be pushing it unless some of those first to files in Novels bag of tricks are pretty big which they might be. i think Novel is worth every bit of 10m maybe 2x that but to do a deal, you may have to settle for what you can get in light of what you want to do.